Low Profile Aortic Stent Graft Systems Gain Popularity with Increased Flexibility and Efficacy

The globally expanding base of elderly people and the rising incidences of aortic aneurysms are essential factors that are anticipated to propel the demand for aortic stents grafts in the near future. The possibility of being afflicted by the condition of abdominal aortic aneurysm (AAA) increases with the growth of the age. Consequently, the number of AAA cases is expected to increase with a growing aging population.

This is creating a greater demand for aortic stent grafts, which is a new treatment, which is rapidly being adopted as an efficient option for treating aneurysms. The procedure of endovascular repair involves the application of a stent graft, in an arterial blood vessel.

The treatment for aortic aneurysm can involve a wide variety of stent grafts. The grafts can vary depending on the design, deployment process, and the manufacturing material. Aortic stent grafts Find extensive application in endovascular repair procedures for abdominal or thoracic aortic aneurysms.

New EVAR Technology Enhances Stent Durability and Modifications

Since the introduction of the endovascular aneurysm repair (EVAR), efforts have been made continuously by manufacturers to improve on the design of aortic stent grafts. The EVAR procedure has grown in popularity owing to the reduced mortality and morbidity rates the procedure provides in comparison to that of open surgeries, allowing for greater intervention and conversion rates.

To find a solution to these limitations of current EVAR procedures, stent graft manufacturers have started to make use of low-profile delivery systems to enhance factors such as durability and functionality through modifications.

By using ultra-low-profile devices, the functionality of EVAR procedures can be boosted significantly through a wider range of arterial anatomic requirements that can be found, in addition to enhancing the device’s deliverability for a vast patient base.

The INCRAFT® System by Cordis Corporation is widely through to be an improved system for referrals in regards to the EVAR technology, instead of being used as device only for bailout procedures while operating in challenging surgical procedures. The addition of this device profile is vital in terms of extra value for any patient who may be suffering from AAA.

Moreover, the EVAR procedure involving the INCRAFT system allows healthcare professionals to consider using only local anesthesia during the operation, and providing an early release to the patient from the hospital.

Researchers are conducting clinical trials to test the benefits of using pre-cutaneous access in comparison to open exposure to the femoral area.

Non-Invasive and Minimally Invasive Surgery Drive Production

As per a recent study conducted by Future Market Insights on the global aortic stent grafts market, the worldwide demand for aortic stent grafts is rising rapidly largely owing to the growing incidences of aortic aneurysms. Growing use of endovascular repairing procedures in completing open surgeries and higher rates of life expectancy, owing to better healthcare facilities are anticipated to create a favorable environment for the production of aortic stent grafts.

In addition, various insurance companies are setting up reimbursement policies that are encouraging the use of minimally invasive surgeries, and consequently the use of aortic stent grafts as well. Growing efforts by researchers for conducting clinical trials to gain the approval of the FDA for new innovations in the designs of aortic stent grafts, to meet the anatomical needs of an ailing body are likely to increase treatment options for aneurysm patients. Moreover, efforts towards business collaboration for improved R&D, are also expected to increase the demand for aortic stent grafts.

On the other hand, a shortage of healthcare professionals with the requisite training, design defects leading to product recalls, lack of awareness about the new endovascular aneurysm repair (EVAR) treatment options and health complications associated to stent grafts are key factors that are expected to hinder the market growth.

Find actionable insights on the newest developments of the constantly evolving global aortic stent grafts market, here.

About Sandali 225 Articles
A former journalist, Sandali is a content marketer with over 5 years of writing experience, across various industries including Food Innovation, Healthcare, and IoT and Technology. Sandali has been weaving corporate stories for organizations through different forms of impactful marketing content. Her key aim is to strategically align well-crafted narratives with business objectives, translating into a powerful communications platform for the company.